QPWM
NVAX icon

Quadrant Private Wealth Management’s Novavax NVAX Stock Holding History

Quadrant Private Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,508
Closed -$216K – 219
2021
Q4 		$216K Hold
1,508
– – 0.08% 185
2021
Q3 		$313K Sell
1,508
-400
-21% -$88.2K 0.13% 150
2021
Q2 		$405K Buy
1,908
+100
+6% +$18.3K 0.16% 126
2021
Q1 		$328K Sell
1,808
-538
-23% -$107K 0.14% 142
2020
Q4 		$262K Sell
2,346
-62
-3% -$6.59K 0.12% 154
2020
Q3 		$261K Sell
2,408
-175
-7% -$21.3K 0.13% 145
2020
Q2 		$215K Buy
+2,583
New +$98.8K 0.12% 163

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quadrant Private Wealth Management's NVAX Position: Q1 2022 in Review

Quadrant Private Wealth Management sold out of Novavax (NVAX) in Q1 2022, closing a stake of 1,508 shares — an estimated $216K sold.

Quadrant Private Wealth Management first reported a position in NVAX in Q2 2020 and held it in 7 quarters. The position peaked at $405K in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Quadrant Private Wealth Management reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Quadrant Private Wealth Management sold 1,508 Novavax shares in Q1 2022, an estimated $216K.
  • Quadrant Private Wealth Management first reported a position in Novavax in Q2 2020 and held it in 7 quarters.
  • Quadrant Private Wealth Management's Novavax position peaked at $405K in Q2 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Quadrant Private Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.